Paper810281
Intensive immunosuppression in patients with disseminated sclerosis. II. Tolerance to equine IgG and effect on immunoglobulin and complement levels.
Jones VE and 3 others. Clin Exp Immunol, 1975. Cited by 6 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Download JSON
Cite this record
ConductScience Library. Intensive immunosuppression in patients with disseminated sclerosis. II. Tolerance to equine IgG and effect on immunoglobulin and complement levels. Papers, record 810281. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/810281
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Intensive immunosuppression in patients with disseminated sclerosis. II. Tolerance to equine IgG and effect on immunoglobulin and complement levels.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Complement System Proteins | Major topic |
| Immune Tolerance | Major topic |
| Immunoglobulin G | Major topic |
| Immunoglobulins | Major topic |
| Immunosuppression Therapy | Major topic |
| Multiple Sclerosis | Major topic |
| Animals | |
| Antilymphocyte Serum | |
| Horses | |
| Humans | |
| Immunodiffusion | |
| Immunoglobulin A | |
| Immunoglobulin D | |
| Immunoglobulin E | |
| Immunoglobulin M | |
| Injections, Intravenous |
Source PubMed
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14,097,352 | THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. | Biochem J | 1963 | https://conductscience.org/library/papers/14097352 | PubMed |
| 3 | 4,995,934 | The intravenous administration of equine antilymphocytic globulin in renal transplant recipients and the detection of circulating antibodies to equine globulin. | Clin Exp Immunol | 1971 | https://conductscience.org/library/papers/4995934 | PubMed |
| 4 | 4,139,403 | Intensive immunosuppression in the treatment of multiple sclerosis. | Lancet | 1974 | https://conductscience.org/library/papers/4139403 | PubMed |
| 5 | 4,875,623 | The mechanism of immunological paralysis. | Adv Immunol | 1968 | https://conductscience.org/library/papers/4875623 | PubMed |
| 6 | 4,937,967 | Induction of tolerance to antilymphocyte globulin in man. | Transplant Proc | 1971 | https://conductscience.org/library/papers/4937967 | PubMed |
| 7 | 4,956,917 | Immunochemical quantitation of antigens by single radial immunodiffusion. | Immunochemistry | 1965 | https://conductscience.org/library/papers/4956917 | PubMed |
| 8 | 5,095,885 | The clinical use of ALG. | Transplant Proc | 1971 | https://conductscience.org/library/papers/5095885 | PubMed |
| 9 | 4,167,593 | Studies of the effect of induced immune lymphopenia. I. Enhanced effects of rabbit anti-rat lymphocyte globulin in rats tolerant to rabbit immunoglobulin G. | J Immunol | 1967 | https://conductscience.org/library/papers/4167593 | PubMed |
| 10 | 4,174,496 | Prolongation of skin homografts by rabbit anti-mouse lymphocyte serum in mice rendered tolerant to rabbit gamma-globulin. | J Immunol | 1968 | https://conductscience.org/library/papers/4174496 | PubMed |
| 11 | 4,168,325 | Antigenicity in mice of antilymphocyte gamma-globulin. | Nature | 1967 | https://conductscience.org/library/papers/4168325 | PubMed |
| 12 | 4,188,086 | Induction of tolerance in man to horse-IgG. | Lancet | 1969 | https://conductscience.org/library/papers/4188086 | PubMed |
| 13 | 4,977,835 | Rat 7S immunoglobulins: characterization of gamma-2- and gamma-1-anti-haptens antibodies. | Immunology | 1969 | https://conductscience.org/library/papers/4977835 | PubMed |
| 14 | 1,237,376 | Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response. | Clin Exp Immunol | 1975 | https://conductscience.org/library/papers/1237376 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 1,237,376 | Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response. | Clin Exp Immunol | 1975 | https://conductscience.org/library/papers/1237376 | PubMed |
| 599,363 | Antimyelin antibody in multiple sclerosis: no change during immunosuppression. | J Neurol Neurosurg Psychiatry | 1977 | https://conductscience.org/library/papers/599363 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/810281
GET https://conductscience.org/api/papers/v1/810281/authors